Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A complex pheotype in a girl with a novel heterozygous missense variant (p.Ile56Phe) of the GNAS gene. | Orphanet J Rare Dis | 2022 | 35197096 | PubTator, text mining | PubMed |
| Soluble forms of PD-1/PD-L immune checkpoint receptor and ligand in blood serum of breast cancer patients: association with clinical pathologic factors and molecular type of the tumor. | Klin Lab Diagn | 2022 | 35192751 | PubTator, text mining | PubMed |
| Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma. | Clin Cancer Res | 2022 | 35190823 | PubTator, text mining | PubMed |
| Unraveling the Dichotomy of Enigmatic Serine Protease HtrA2. | Front Mol Biosci | 2022 | 35187085 | PubTator, text mining | PubMed |
| Brachydactyly Type A3 Is More Commonly Seen in Children With Short Stature But Does Not Affect Their Height Improvement by Growth Hormone Therapy. | Front Endocrinol (Lausanne) | 2022 | 35185800 | PubTator, text mining | PubMed |
| Cellular and soluble immune checkpoint signaling forms PD-L1 and PD-1 in renal tumor tissue and in blood. | Cancer Immunol Immunother | 2022 | 35184226 | PubTator, text mining | PubMed |
| Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancer. | Cell Death Dis | 2022 | 35169119 | PubTator, text mining | PubMed |
| Immune Dysfunction, Cytokine Disruption, and Stromal Changes in Myelodysplastic Syndrome: A Review. | Cells | 2022 | 35159389 | PubTator, text mining | PubMed |
| Multiple motors cooperate to establish and maintain acentrosomal spindle bipolarity in C. elegans oocyte meiosis. | Elife | 2022 | 35147496 | PubTator, text mining | PubMed |
| The cerebellum and psychological trauma: A systematic review of neuroimaging studies. | Neurobiol Stress | 2022 | 35146077 | PubTator, text mining | PubMed |
| Insights from density functional theory calculations on heteroatom P-doped ZnIn2S4 bilayer nanosheets with atomic-level charge steering for photocatalytic water splitting. | Sci Rep | 2022 | 35121781 | PubTator, text mining | PubMed |
| Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents. | Dermatol Ther (Heidelb) | 2022 | 35088348 | PubTator, text mining | PubMed |
| Prognostic impact of serum soluble PD-1 and ADV score for living donor liver transplantation in patients with previously untreated hepatocellular carcinoma. | Ann Surg Treat Res | 2022 | 35071119 | PubTator, text mining | PubMed |
| Biomarkers for predicting the efficacy of immune checkpoint inhibitors. | J Cancer | 2022 | 35069896 | PubTator, text mining | PubMed |
| Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis. | Lancet Respir Med | 2022 | 35063079 | PubTator, text mining | PubMed |
| A Dual-Channel Intelligent Point-of-Care Testing System for Soluble Programmed Death-1 and Programmed Death-Ligand 1 Detection Based on Folding Paper-Based Immunosensors. | ACS Sens | 2022 | 35060694 | PubTator, text mining | PubMed |
| Clinical Relevance of Soluble Forms of Immune Checkpoint Molecules sPD-1, sPD-L1, and sCTLA-4 in the Diagnosis and Prognosis of Ovarian Cancer. | Diagnostics (Basel) | 2022 | 35054356 | PubTator, text mining | PubMed |
| Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways. | Cells | 2022 | 35053339 | PubTator, text mining | PubMed |
| Molecular Mechanisms in Pentanucleotide Repeat Diseases. | Cells | 2022 | 35053321 | PubTator, text mining | PubMed |
| baredSC: Bayesian approach to retrieve expression distribution of single-cell data. | BMC Bioinformatics | 2022 | 35021985 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=27